Global Enteral Feeding Formulas Market Size (2024 - 2029)

The enteral feeding formulas market is projected to experience growth driven by factors such as the increasing prevalence of metabolic and chronic disorders, rising healthcare expenditure, and a growing geriatric population. The market's expansion is further supported by the heightened demand for enteral nutrition, particularly in the context of COVID-19, where nutritional management became crucial for critically ill patients. Post-pandemic, the demand continues to rise due to the increased adoption of enteral feeding formulas in hospitals and home healthcare settings. Additionally, initiatives by key market players to launch new products are expected to contribute to market growth. However, challenges such as complications associated with enteral nutrition and high costs in developing regions may hinder market expansion.

Market Size of Global Enteral Feeding Formulas Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Enteral Feeding Formulas Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 8.77 Billion
Market Size (2029) USD 11.30 Billion
CAGR (2024 - 2029) 5.18 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Enteral Feeding Formulas Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Enteral Feeding Formulas Market Analysis

The Global Enteral Feeding Formulas Market size is estimated at USD 8.77 billion in 2024, and is expected to reach USD 11.30 billion by 2029, growing at a CAGR of 5.18% during the forecast period (2024-2029).

The outbreak of COVID-19 is expected to impact the enteral feeding formulas market, as good supportive care remains the cornerstone in managing critically ill patients with COVID-19 infection, within which nutritional management of the ICU admitted COVID-19 patients is an integral component of the supportive measures. For instance, according to the study published in Nutrients in March 2022, to prevent malnutrition in COVID-19 individuals, prompt enteral nutrition support and the administration of adequate nutrients were crucial. Additionally, it is advised for critically ill patients for enteral feeding assistance. Such instances might have been expected to drive the market during the pandemic. Furthermore, post-pandemic, there has been an increased demand for these formulas due rise in enteral feeding formulas, a rise in the prevalence of diseases, and a rise in the number of hospitals, among others.

The enteral feeding formula market is primarily driven by the increasing prevalence of metabolic and chronic disorders, increased expenditure on patient care, and the growing geriatric population. According to the IDF 2021, approximately 537 million adults are living with diabetes, and the number of people adults living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Such a rise in metabolic diseases is expected to drive market growth due to a rise in the adoption of enteral feeds for diabetic patients, as diabetes-specific nutrition formulas (DSNFs) can help control the development, progression, and severity of certain chronic diseases.

Also, aging is the primary factor driving the market growth for the treatment. According to the United Nations Department of Economics and Social 2022 report, there were 771 million people aged 65 years or over globally in 2022, and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. Thus, the demand for enteral nutrition will rise with the growing geriatric population due to the increased adoption of enteral feeding formulas in the elderly. Furthermore, the rising healthcare expenditure in developed and developing countries and the increasing demand for home healthcare services will also boost the enteral feeding formula market growth.

Furthermore, the rise in initiatives from the key market players for the launch of their products is expected to drive market growth. For instance, in May 2022, Abbott decided to release EleCare specialty amino acid-based formulas in infants and children who have severe food allergies or gastrointestinal (GI) disorders., Such instances are also expected to drive market growth due to the rise in adoption in pediatrics.

However, complications associated with enteral nutrition and high cost and low adherence rates in developing countries are the factors expected to impede market growth.

Enteral Feeding Formulas Industry Segmentation

As per the scope of the report, enteral feeding refers to the delivery of a nutritionally complete feed containing protein, carbohydrates, fat, water, minerals, and vitamins directly into the stomach, duodenum, or jejunum. The report is segmented by Product (Standard Formulas and Disease-specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), End-User (Hospitals, Home Care Agencies, and Hospices, and Other End User), Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Standard Formulas
Disease-specific Formulas
By Application
Oncology
Neurology
Critical Care
Diabetes
Gastroenterology
Other Applications
By End User
Hospital
Home Care Agencies and Hospices
Other End Users
By Distributuion Channel
Hospitals
Retail Pharmacies
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Enteral Feeding Formulas Market Size Summary

The enteral feeding formulas market is poised for significant growth, driven by the increasing prevalence of chronic and metabolic disorders, such as diabetes and cancer, and the expanding geriatric population. The market's expansion is further supported by rising healthcare expenditures and the growing demand for home healthcare services. The COVID-19 pandemic has also highlighted the importance of nutritional management in critically ill patients, which has contributed to the market's growth. Key players in the industry are actively launching innovative products, such as specialty amino acid-based formulas and plant-based nutrition solutions, to cater to diverse patient needs, including those with severe food allergies or gastrointestinal disorders. These developments are expected to bolster the market's trajectory over the forecast period.

North America is anticipated to dominate the enteral feeding formulas market due to its rapidly aging population and the high prevalence of chronic diseases, which necessitate prolonged hospital stays and nutritional support. The region's market growth is further fueled by the presence of major industry players and their continuous product innovations. The market is moderately fragmented, with key companies like Abbott Laboratories, Nestle SA, and Fresenius Kabi AG leading the charge. Despite challenges such as high costs and low adherence rates in developing countries, the market is expected to thrive, driven by the increasing adoption of enteral feeding formulas in various patient demographics, including the elderly and those with cancer.

Explore More

Global Enteral Feeding Formulas Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Metabolic and Chronic Diseases

      2. 1.2.2 Increasing Spending on Patient Care

      3. 1.2.3 Growing Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Complications Associated with Enteral Nutrition

      2. 1.3.2 High Cost and Low Adherence Rates in Developing Countries

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Standard Formulas

      2. 2.1.2 Disease-specific Formulas

    2. 2.2 By Application

      1. 2.2.1 Oncology

      2. 2.2.2 Neurology

      3. 2.2.3 Critical Care

      4. 2.2.4 Diabetes

      5. 2.2.5 Gastroenterology

      6. 2.2.6 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospital

      2. 2.3.2 Home Care Agencies and Hospices

      3. 2.3.3 Other End Users

    4. 2.4 By Distributuion Channel

      1. 2.4.1 Hospitals

      2. 2.4.2 Retail Pharmacies

      3. 2.4.3 Online Pharmacies

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Global Enteral Feeding Formulas Market Size FAQs

The Global Enteral Feeding Formulas Market size is expected to reach USD 8.77 billion in 2024 and grow at a CAGR of 5.18% to reach USD 11.30 billion by 2029.

In 2024, the Global Enteral Feeding Formulas Market size is expected to reach USD 8.77 billion.

Enteral Feeding Formulas Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)